secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aceragen, Inc. (—)
CIK:        0000861838
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001104659-22-121727
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Idera Pharmaceuticals receives Nasdaq delisting notice over bid price non-compliance
--------------------------------------------------------------------------------

- Notified by Nasdaq Staff of delisting due to continued non-compliance with minimum $1.00 bid price.
- Company plans to timely request a hearing before Nasdaq Hearings Panel to stay delisting.
- Previous grace periods expired on November 21, 2022; no further automatic compliance period.
- Panel may grant extension up to 180 days, through May 22, 2023, at its discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/861838/000110465922121727/0001104659-22-121727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/861838/000110465922121727/tm2231244d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-121727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer